Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?

Masataka Yokode; Masahiro Shiokawa; Yuzo Kodama

doi:10.3390/diagnostics11050770

Diagnostics (Apr 2021)

Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?

Masataka Yokode,
Masahiro Shiokawa,
Yuzo Kodama

Affiliations

Masataka Yokode: Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
Masahiro Shiokawa: Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
Yuzo Kodama: Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

DOI: https://doi.org/10.3390/diagnostics11050770
Journal volume & issue: Vol. 11, no. 5
p. 770

Abstract

Read online

Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potential diagnostic biomarkers for AIP. Many investigations have been conducted, but no specific biomarkers for AIP are identified. Therefore, further studies are required to identify accurate diagnostic biomarkers for AIP.

Published in Diagnostics

ISSN: 2075-4418 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Medicine (General)
Website: http://www.mdpi.com/journal/diagnostics

About the journal

Abstract

Keywords